Nautilus Biotechnology says biological validation remains one of proteomics’ biggest bottlenecks and is urging the field to rethink current methods. The push co

Nautilus Biotechnology says biological validation remains one of proteomics’ biggest bottlenecks and is urging the field to rethink current methods. The push comes as Nautilus expands its Voyager platform and free analysis-tool access for researchers.